tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kalpit Patel, 57 are a BUY (79.17%), 15 are a HOLD (20.83%).
Analyst Kalpit Patel, currently employed at B. RILEY, carries an average stock price target met ratio of 38.1% that have a potential upside of 70.37% achieved within 177 days.
Kalpit Patel’s has documented 142 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LBPH, Longboard Pharmaceuticals at 14-Oct-2024.
Analyst best performing recommendations are on RIGL (RIGEL PHARMACEUTICALS).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/9/2022. The price target of $12.5 was fulfilled within 22 days with a profit of $5.32 (74.09%) receiving and performance score of 33.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$55
$34.31 (165.83%)
$55
22 days ago
(01-Nov-2024)
1/12 (8.33%)
$31.14 (130.51%)
83
Buy
$38
$17.31 (83.66%)
$38
23 days ago
(31-Oct-2024)
0/16 (0%)
$13.97 (58.14%)
Buy
$32
$11.31 (54.66%)
$32
2 months 7 days ago
(16-Sep-2024)
1/10 (10%)
$7.03 (28.15%)
174
Buy
$65
2 months 14 days ago
(09-Sep-2024)
0/5 (0%)
$49.66 (323.73%)
Buy
$28
$7.31 (35.33%)
$33
3 months 16 days ago
(07-Aug-2024)
1/7 (14.29%)
$3.62 (14.85%)
13
Which stock is Kalpit Patel is most bullish on?
Which stock is Kalpit Patel is most reserved on?
What Year was the first public recommendation made by Kalpit Patel?
